Anarob | Pakistan

Pakistan’s Drug Regulatory Authority (Drap) on Tuesday ordered the withdrawal of a batch of Anarob antibiotic drip after it was found to contain harmful levels of bacterial toxins. Anarob Infusion is an intravenous antibiotic drip containing metronidazole, commonly used in hospitals to treat serious bacterial infections in the stomach, skin, lungs, joints, and other parts of the body when oral medicines are not effective. A medical product alert issued today said Drap’s Central Drugs Laboratory had informed the body that samples of the drug were declared “substandard” due to being out of specification for bacterial endotoxins. “Use of this contaminated infusion may cause severe adverse reactions such as fever, chills, septic shock and life-threatening complications. Hospitalised and immunocompromised patients are at the greatest risk,” the authority warned. It said its field force and Provincial Drug Control departments were directed to immediately conduct market surveys to detect and remove the affected batc...